lais da silva pereira
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Vaccines and Molecular Therapeutics
National Institutes of Health (NIH)
Bethesda, United States
Review Editor
Vaccines and Molecular Therapeutics
Mayo Clinic
Rochester, United States
Review Editor
Vaccines and Molecular Therapeutics
University of California, San Diego
La Jolla, United States
Review Editor
Vaccines and Molecular Therapeutics
Feinberg School of Medicine, Northwestern University
Chicago, United States
Review Editor
Vaccines and Molecular Therapeutics
School of Medicine, Washington University in St. Louis
St. Louis, United States
Review Editor
Vaccines and Molecular Therapeutics
Cleveland Clinic
Cleveland, United States
Review Editor
Vaccines and Molecular Therapeutics
University of Maryland
Baltimore, United States
Review Editor
Vaccines and Molecular Therapeutics
QIMR Berghofer Medical Research Institute, The University of Queensland
Herston, Australia
Review Editor
Vaccines and Molecular Therapeutics
University of Florida
Gainesville, United States
Review Editor
Vaccines and Molecular Therapeutics
Carlos III Health Institute (ISCIII)
Madrid, Spain
Review Editor
Vaccines and Molecular Therapeutics
Center of Immunology, Adolfo Lutz Institute
Sao Paulo, Brazil
Review Editor
Vaccines and Molecular Therapeutics
Novartis (United States)
East Hanover, United States
Review Editor
Vaccines and Molecular Therapeutics
EpiVax (United States)
Providence, United States
Review Editor
Vaccines and Molecular Therapeutics
argenx BVBA
Zwijnaarde, Belgium
Review Editor
Vaccines and Molecular Therapeutics
Roche Pharma Research and Early Development, Roche Innovation Center
Basel, Switzerland
Review Editor
Vaccines and Molecular Therapeutics
University of Genoa
Genoa, Italy
Review Editor
Vaccines and Molecular Therapeutics